Remove Health Policy Remove Pharmaceuticals Remove Telemedicine
article thumbnail

Telehealth Legislation Passes Ways & Means, As GLP-1s Are Fast-Meshing with Telemedicine in the Marketplace

Health Populi

platforming telehealth with weight loss and the fast-growing medicine category — such as Eli Lilly Direct, the pharmaceutical company planning to go direct-to-consumer to channel patients’ access to and use of Zepbound for weight loss (partnering with Amazon’s pharmacy for delivery).

article thumbnail

Ten In Ten: Manatt’s Healthcare Priorities to 2031

Health Populi

Note that WHO’s approach to digital health adoption includes equity, access, palliative care, privacy, and security.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

HLTH 2024: What are the key talking points likely to be?

Lloyd Price

The challenges and opportunities of integrating social determinants of health into care delivery. Health Policy: The impact of healthcare policy on patient outcomes and access to care. Climate Change and Health: Examining the health implications of climate change and strategies for sustainable healthcare practices.

article thumbnail

The Home and Low-Touch Health Care – a Health Consumer Update from Capgemini

Health Populi

Capgemini offers recommendations to providers, pharmaceutical companies, and medical device manufacturers to tap opportunities outside of inpatient settings and, increasingly, to the home and digital device. These trends point to more care being demanded by patients outside of the legacy care system, at home and via more virtual platforms.

article thumbnail

Telehealth-As-Healthcare Is a Mainstream Expectation Among Consumers, J.D. Power Finds

Health Populi

Telehealth has increased access to mental health services, I’ve highlighted this Mental Illness Awareness Week here in Health Populi. But telehealth has also emerged as a preferred channel for routine health care services, we learn from J.D. Power’s 2022 Telehealth Satisfaction Study.

article thumbnail

COVID-19 Implications for pharma: US payer insights

Henry Kotula

In the short-term emergency healthcare packages have included increasing patient access to medicines, waiving co-pays, relaxing prior approval requirements and increasing telemedicine services. How might COVID-19 impact policy on co-payments, premiums and patient selection criteria for treatments in the future? But longer term?

article thumbnail

Health Equity: Searching for a New Angle

Healthcare IT Today

From virtual and hybrid site models, eClinical platforms, data-driven recruitment strategies, mobile sample collections, telemedicine, and more, industry leaders can expand patients’ access to trials, helping to ensure all necessary populations are represented in clinical research.